The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis
{{output}}
The aim of this 12-month, observational study was to compare the effects of switching daily teriparatide (TPTD) to oral bisphosphonates (BP) therapy or denosumab (DMAb) therapy in patients with primary osteoporosis. Patients [n = 78; 71 postmenopausal women an... ...
